Biotoxtech Co., Ltd. (KOSDAQ:086040)

Biotoxtech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	45,983	44,254	52,429	98,113	119,140	117,384
Market Cap Growth	0.34%	-15.59%	-46.56%	-17.65%	1.50%	-47.09%
Enterprise Value	72,125	75,280	78,212	127,342	128,169	118,446
Last Close Price	2925.00	2815.00	3335.00	6160.00	8140.00	8020.00
PE Ratio	39.30	38.06	-	-	43.72	16.50
PS Ratio	0.98	0.94	1.27	3.01	3.20	3.59
PB Ratio	1.44	1.39	1.52	2.03	2.69	2.81
P/TBV Ratio	1.18	1.14	1.37	1.96	2.79	2.96
P/FCF Ratio	10.18	9.80	-	-	-	-
P/OCF Ratio	6.93	6.67	-	-	-	27.01
EV/Sales Ratio	1.53	1.60	1.89	3.90	3.44	3.62
EV/EBITDA Ratio	-	-	-	-	46.70	18.79
EV/EBIT Ratio	-	-	-	-	160.20	25.57
EV/FCF Ratio	15.97	16.67	-	-	-	-
Debt / Equity Ratio	1.96	1.96	1.83	1.28	1.11	0.65
Debt / EBITDA Ratio	-	-	-	-	17.90	4.29
Debt / FCF Ratio	13.84	13.84	-	-	-	-
Net Debt / Equity Ratio	1.08	1.08	0.89	0.43	0.41	-0.03
Net Debt / EBITDA Ratio	-21.81	-21.81	-6.78	-4.11	6.69	-0.17
Net Debt / FCF Ratio	7.61	7.61	-3.37	-0.99	-0.57	0.34
Asset Turnover	0.35	0.35	0.29	0.24	0.35	0.42
Inventory Turnover	3.75	3.75	2.91	3.76	9.70	29.42
Quick Ratio	0.44	0.44	0.50	0.62	0.64	0.77
Current Ratio	0.57	0.57	0.72	0.86	0.83	0.83
Return on Equity (ROE)	-4.74%	-4.74%	-30.59%	-19.33%	0.15%	17.59%
Return on Assets (ROA)	-2.76%	-2.76%	-3.80%	-3.98%	0.46%	3.75%
Return on Invested Capital (ROIC)	-8.47%	-8.99%	-12.87%	-13.19%	1.55%	13.03%
Return on Capital Employed (ROCE)	-12.80%	-12.80%	-16.00%	-12.10%	1.20%	10.30%
Earnings Yield	2.53%	2.63%	-12.26%	-4.97%	2.29%	6.06%
FCF Yield	9.82%	10.20%	-17.35%	-21.09%	-26.85%	-2.79%
Buyback Yield / Dilution	1.56%	1.56%	-2.86%	-5.42%	4.91%	-5.41%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.